SARS-CoV 2 imaging study award to the UK Biobank
- Funded by UK Research and Innovation (UKRI)
- Total publications:5 publications
Grant number: MC_PC_21051
Grant search
Key facts
Disease
COVID-19Start & end year
20212022Known Financial Commitments (USD)
$4,763,304.27Funder
UK Research and Innovation (UKRI)Principal Investigator
Mark EffinghamResearch Location
United KingdomLead Research Institution
UK BiobankResearch Priority Alignment
N/A
Research Category
14
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
Not applicable
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The Medical Research Council (MRC) has agreed to provide a COVID-19 Support Fund award to UK Biobank to help underpin short-term stability and to avoid deterioration of strategic, national scientific capability as a result of impacts of the COVID-19 pandemic. Purpose By accepting this award, the organisation agrees to use the MRC COVID-19 Support Fund to help ensure MRC objectives continue to be met, the value of MRC investments continue to be realised, and to sustain the research skills and capability within their organisation that will be needed to underpin the post-pandemic national recovery. The award is specifically to maximise the number of participants within the core imaging programme.
Publicationslinked via Europe PMC
Last Updated:an hour ago
View all publications at Europe PMC